Evidence map›Paper›PMID 33163815›Full record

ArticleACS omega2020

Naringin in Combination with Isothiocyanates as Liposomal Formulations Potentiates the Anti-inflammatory Activity in Different Acute and Chronic Animal Models of Rheumatoid Arthritis.

Sangeeta Mohanty, Ashish Kumar Sahoo, V Badireenath Konkimalla, Abhisek Pal, Sudam Chandra Si

Erratum issuedOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Sangeeta MohantySchool of Pharmaceutical Sciences, Siksha O Anusandhan Deemed to Be University, Bhubaneswar 751030, India.
Ashish Kumar SahooSchool of Biological Sciences, National Institute of Science Education and Research, HBNI, Jatni, Odisha 752050, India.
V Badireenath KonkimallaSchool of Biological Sciences, National Institute of Science Education and Research, HBNI, Jatni, Odisha 752050, India.
Abhisek PalGitam School of Pharmacy, Gitam Deemed to Be University, Hyderabad 502329, India.
Sudam Chandra SiSchool of Pharmaceutical Sciences, Siksha O Anusandhan Deemed to Be University, Bhubaneswar 751030, India.
National Institute of Science Education and Research · INSiksha O Anusandhan University · INGITAM University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Combination of drugs is extensively used to treat chronic inflammatory disease. Naringin (NAR), sulforaphane (SFN), and phenethyl isothiocyanate (PEITC) are nutraceuticals with promising anti-inflammatory properties. However, their clinical effectiveness gets hindered because of low aqueous solubility and poor bioavailability. In the current study, two combinations of liposome (NAR + SFN and NAR + PEITC) were prepared and studied thoroughly in different

Identifiers

PMID33163815
PMCPMC7643286
OpenAlexW3096473443

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.